We report a rare case of acute neurological Behçet’s disease (neuro-BD) diagnosed concurrently with systemic Behçet’s disease ...
Targets Critical Gaps In CTCL Treatment With Hybryte(TM). Cutaneous T-cell lymphoma, or CTCL, is recognized by clinicians as one of the most difficult cancers to diagnose accurately in its early ...
In Growing Biodefense Preparedness Efforts. Soligenix (NASDAQ: SNGX), a biopharmaceutical company focused on biodefense solutions, was featured in a recent article discussing its development of a vacc ...
A 58-year-old woman was admitted to the hospital 3 weeks after lumbar surgery because of diplopia and fever. Left leg pain and a rash had preceded the fever and diplopia. A diagnosis was made.
EQT Life Sciences is pleased to announce that its LSP Dementia Fund has co-led a EUR 51 million Series B in Exciva (the "Company"), a clinical-stage biopharmaceutical company developing novel ...
The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.
D3 Bio, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two ...
Soligenix (NASDAQ: SNGX) is a New Jersey-based biopharmaceutical company focused on developing products to treat rare diseases where there is an unmet medical need. The company recently received ...
PIP is broken down into two parts with daily living starting at £73.90 for the lower rate, rising to £110.40 for higher ...
In 1906, Alois Alzheimer first described an unusual set of symptoms, including behavioural disturbances and memory loss, in a relatively young patient named Auguste Deter. We now know this to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results